A5024304733- Renal Transplantation Outcomes and Treatments
- Organ Transplantation Techniques and Outcomes
- Transplantation: Methods and Outcomes
- Hormonal Regulation and Hypertension
- Parathyroid Disorders and Treatments
- Blood groups and transfusion
- Renal Diseases and Glomerulopathies
- Pneumocystis jirovecii pneumonia detection and treatment
- Liver Disease Diagnosis and Treatment
- Diversity and Career in Medicine
- Trace Elements in Health
- Cardiac, Anesthesia and Surgical Outcomes
- Pituitary Gland Disorders and Treatments
- Diet and metabolism studies
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Adrenal Hormones and Disorders
- Folate and B Vitamins Research
- Medical Education and Admissions
- Genetic Syndromes and Imprinting
- Organ Donation and Transplantation
- Pharmacological Effects and Toxicity Studies
- Hospital Admissions and Outcomes
- Thyroid Cancer Diagnosis and Treatment
- Immunodeficiency and Autoimmune Disorders
- Bone health and treatments
The University of Texas Southwestern Medical Center
2019-2024
Southwestern Medical Center
2020-2024
Toronto General Hospital
2020
Methodist Hospital
2014-2017
Texas A&M Health Science Center
2009
Abstract Background The natural history of de novo donor‐specific antibodies ( dn DSA ) after lung transplantation is not well‐described. We sought to determine the incidence and risk factors associated with compare outcomes between recipients transient (or isolated) vs persistent transplantation. Methods A single‐center review all transplants from 1/2009‐7/2013. s were tested eight times in first year every 4 months thereafter. Outcomes examined included acute rejection graft failure....
Background. Excessive weight (EW) gain is common after solid organ transplantation, but there little information concerning obesity pancreas transplantation. The study goal was to characterize EW kidney-pancreas (KP) Methods. This a retrospective single-center review of 100 KP recipients transplanted between September 2007 and June 2015. Results. median percent for all at 1 year posttransplant 10% (interquartile range, 2.7%–19.3%) baseline weight. gain, defined as greater than or equal 19%...
Abstract TXN2 encodes human thioredoxin 2, a small redox protein important in cellular antioxidant defenses, as well the regulation of apoptosis. Txn2 knockout mice fail to complete neural tube closure by E10.5 and die utero. We hypothesized that genetic variation gene may alter function encoded manner associated with an increased risk for defects (NTDs). A DNA re‐sequencing effort was taken. After promoter identified, transcriptional activity different alleles investigated. The possible...
Background . Acceptance of dual kidney transplantation (DKT) has proven difficult, due to surgical complexity and concerns regarding long-term outcomes. We herein present a standard technique for ipsilateral DKT compare outcomes single-kidney transplant (SKT) recipients. Methods A retrospective single-center comparison SKT performed between February 2007 July 2013. Results Of 516 deceased donor transplants, 29 were 487 SKT. Mean follow-up was 43 ± 67 months. recipients older more likely than...
Abstract Disclosure: J.E. Mosquera: None. S. Agarwal: M. Maxwell: T. Bryson: Mirfakhraee: A. Berry: M.M. Johny: S.C. Oltmann: Mehta: A.P. Dackiw: Islam: F. Nwariaku: J. Cadeddu: Woldu: L. Jia: O. Hamidi: Advisory Board Member; Self; Corcept Therapeutics. Background: Surgical tumor resection is the only curative treatment for localized pheochromocytoma and functioning paraganglioma (PPGL). Adequate preoperative preparation with alpha-adrenergic blockers key before surgical resection. However,...
Abstract Disclosure: O. Hamidi: Advisory Board Member; Self; Corcept, Neurocrine Biosciences, Amryt Pharma, Recordati Rare Diseases, Lantheus, Xeris. B.H. Salama: None. P. Dogra: A.P. Dackiw: F. Nwariaku: A. Islam: Mehta: S.C. Oltmann: S. Mirfakhraee: T. McKenzie: T.R. Foster: M. Lyden: B.M. Dy: I. Bancos: Introduction: Patients with mild autonomous cortisol secretion (MACS) are at risk for adrenal insufficiency (AI) after unilateral adrenalectomy. We aimed to determine the prevalence,...
Background: Prospective monitoring of de novo donor specific antibodies (dnDSA) after renal transplant has shown that dnDSA are predictive poor outcomes. The immunomodulatory effects intravenous immune globulin (IVIG) may be beneficial for pre-emptive treatment recipients without acute rejection (AR). Herein, we present preliminary data with and stable function treated IVIG compared to matched controls. Methods: We prospectively monitored all kidney from 7/2007-7/2012. Recipients 2 or more...
Background: Most studies have focused on single time point detection of de novo donor specific antibodies (dnDSA) and adverse outcomes after renal transplant. Longitudinal sensitized dialysis patients reported that some spontaneously clear antibodies, but the pattern impact antibody clearance is unknown. We sought to determine rate spontaneous dnDSA transplant describe associated with versus persistence in without prior rejection. Methods: prospectively monitored 828 kidney transplants for...
Background: The pattern of clearance or persistence de novo donor specific anti-HLA antibodies (dnDSA) is unclear in lung transplant recipients. purpose our study to identify the incidence dnDSA and its a population prospectively monitored recipients predictive factors for clearance. Methods: We reviewed 325 first-time, lung-only from 1/2009-11/2012 who all had at least 1 year follow-up. Of these, we excluded 53 patients DSA prior (6), within 14 days < 2 tests (16), desensitization (22)...